Hosted on MSN

Is Retatrutide the next weight-loss breakthrough after Ozempic and Mounjaro? Here’s how it works differently

A new weight-loss drug often described as the “triple G” treatment because it mimics three hormones linked to hunger and metabolism has delivered striking results in fresh data shared Thursday by its ...
Morningstar

Lilly's triple agonist, retatrutide, delivered weight loss of up to an average of 71.2 lbs along with substantial relief from osteoarthritis pain in first successful Phase 3 trial

iPercent change in the WOMAC pain subscale score and percent change in the WOMAC physical function subscale score were not pre-specified and were estimated from a post-hoc analysis. iiNot controlled ...
Daily Sundial

Retatrutide Reviews and Results for Weight Loss: Retatritide Compared to Ozempic and Wegovy

The world is full of overweight and obese people who find it impossible to lose weight by diet and exercise alone. Many of them are desperate to find a weight management product that can help them ...
Everyday Health

New Obesity Drug Helped People Lose Nearly One-Third Their Body Weight

The experimental medication retatrutide appears to be more effective than existing GLP-1 drugs because it targets 3 hormones: GLP-1, GIP, and glucagon. People taking the experimental obesity drug ...